PURPOSE: To review the role of ocular perfusion in the pathophysiology of age-related macular degeneration (AMD), the leading cause of irreversible blindness in the industrialized world. METHODS: Medline search of the literature published in English or with English abstracts from 1966 to 2000 was performed using various combinations of relevant key words. RESULTS: Vascular defects have been identified in both nonexudative and exudative AMD patients using fluorescein angiographic methods, laser Doppler flowmetry, indocyanine green angiography, and color Doppler imaging. CONCLUSION: Although these studies lend some support to the vascular pathogenesis of AMD, it is not possible to determine if the choroidal perfusion abnormalities play a causative role in nonexudative AMD, if they are simply an association with another primary alteration, such as a primary RPE defect or a genetic defect at the photoreceptor level, or if they are more strongly associated with one particular form of this heterogeneous disease. Further study is warranted.
PURPOSE: To review the role of ocular perfusion in the pathophysiology of age-related macular degeneration (AMD), the leading cause of irreversible blindness in the industrialized world. METHODS: Medline search of the literature published in English or with English abstracts from 1966 to 2000 was performed using various combinations of relevant key words. RESULTS:Vascular defects have been identified in both nonexudative and exudative AMDpatients using fluorescein angiographic methods, laser Doppler flowmetry, indocyanine green angiography, and color Doppler imaging. CONCLUSION: Although these studies lend some support to the vascular pathogenesis of AMD, it is not possible to determine if the choroidal perfusion abnormalities play a causative role in nonexudative AMD, if they are simply an association with another primary alteration, such as a primary RPE defect or a genetic defect at the photoreceptor level, or if they are more strongly associated with one particular form of this heterogeneous disease. Further study is warranted.
Authors: Anton Reiner; Nobel Del Mar; Yuri Zagvazdin; Chunyan Li; Malinda E C Fitzgerald Journal: Invest Ophthalmol Vis Sci Date: 2011-09-14 Impact factor: 4.799
Authors: Nathan G Lambert; Hanan ElShelmani; Malkit K Singh; Fiona C Mansergh; Michael A Wride; Maximilian Padilla; David Keegan; Ruth E Hogg; Balamurali K Ambati Journal: Prog Retin Eye Res Date: 2016-05-06 Impact factor: 21.198
Authors: Thomas A Ciulla; Alon Harris; Larry Kagemann; Ronald P Danis; Linda M Pratt; Hak S Chung; Dov Weinberger; Hanna J Garzozi Journal: Br J Ophthalmol Date: 2002-02 Impact factor: 4.638
Authors: Audrey B Condren; Anil Kumar; Pradeep Mettu; Katharine J Liang; Lian Zhao; Jen-yue Tsai; Robert N Fariss; Wai T Wong Journal: PLoS One Date: 2013-01-04 Impact factor: 3.240
Authors: Rita Ehrlich; Alon Harris; Nisha S Kheradiya; Diana M Winston; Thomas A Ciulla; Barbara Wirostko Journal: Clin Interv Aging Date: 2008 Impact factor: 4.458